Literature DB >> 14370401

Multiple sclerosis and amyotrophic lateral sclerosis; etiologic significance of recent epidemiologic and genetic studies.

L T KURLAND, D W MULDER, K B WESTLUND.   

Abstract

Entities:  

Keywords:  AMYOTROPHIC LATERAL SCLEROSIS/heredity; MUMPS/epidemiology

Mesh：

Year:  1955        PMID： 14370401     DOI： 10.1056/NEJM195504212521601

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  GEOGRAPHIC AND CLIMATIC ASPECTS OF MULTIPLE SCLEROSIS; A REVIEW OF CURRENT HYPOTHESES.

Authors:  L T KURLAND; D REED
Journal:  Am J Public Health Nations Health       Date:  1964-04

2.  MULTIPLE SCLEROSIS AND POLIOMYELITIS IN AUSTRALASIA.

Authors:  M J EADIE; J M SUTHERLAND; J H TYRER
Journal:  Br Med J       Date:  1965-06-05

3.  [On the genetics and demography of Charcot's disease in the area of Westphalia].

Authors:  W F HABERLANDT
Journal:  Dtsch Z Nervenheilkd       Date:  1959

4.  Treatment of narcolepsy with methamphetamine.

Authors:  M M Mitler; R Hajdukovic; M K Erman
Journal:  Sleep       Date:  1993-06       Impact factor: 5.849

5.  STUDY OF THE ETIOLOGY OF AMYOTROPHIC LATERAL SCLEROSIS.

Authors:  L A ZILBER; Z L BAJDAKOVA; A N GARDASJAN; N V KONOVALOV; T L BUNINA; E M BARABADZE
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

6.  Ethnic and HLA patterns related to multiple sclerosis in Wellington, New Zealand.

Authors:  D H Miller; R W Hornabrook; J Dagger; R Fong
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-01       Impact factor: 10.154

7.  Epidemiological study of multiple sclerosis in Israel. II. Multiple sclerosis and level of sanitation.

Authors:  U Leibowitz; A Antonovsky; J M Medalie; H A Smith; L Halpern; M Alter
Journal:  J Neurol Neurosurg Psychiatry       Date:  1966-02       Impact factor: 10.154

8.  Narcolepsy.

Authors:  M M Mitler; R Hajdukovic; M Erman; J A Koziol
Journal:  J Clin Neurophysiol       Date:  1990-01       Impact factor: 2.177
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.